Researchers are excited about this new drug, a groundbreaking dual compound showing promising data in initial trials for weight reduction . It acts by targeting two pathways : GLP-1 and GIP, which , https://jaysondvtr031791.full-design.com/a-new-hope-for-body-management-83372097